Steven McQuillan's most recent trade in Acutus Medical Inc was a trade of 733 Common Stock done at an average price of $1.3 . Disclosure was reported to the exchange on April 1, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Acutus Medical Inc | Steven McQuillan | SVP, Clinical Affairs & QA | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.30 per share. | 01 Apr 2022 | 733 | 45,844 | - | 1.3 | 953 | Common Stock |
| Acutus Medical Inc | Steven McQuillan | SVP, Clinical Affairs & QA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 32,000 | 46,577 | - | 0 | Common Stock | |
| Acutus Medical Inc | Steven McQuillan | SVP, Clinical Affairs & QA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 32,000 | 32,000 | - | - | Stock Options (Right to Buy) | |
| Acutus Medical Inc | Steven McQuillan | SVP, Clinical Affairs & QA | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.52 per share. | 05 Aug 2021 | 305 | 14,577 | - | 15.5 | 4,734 | Common Stock |
| Acutus Medical Inc | Steven McQuillan | SVP, Clinical Affairs & QA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 34,800 | 34,800 | - | - | Stock Options (Right to Buy) | |
| Acutus Medical Inc | Steven McQuillan | SVP, Clinical Affairs & QA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 9,882 | 14,882 | - | 0 | Common Stock |